Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

The development of new treatments for lung cancer.

VOL: 102, ISSUE: 16, PAGE NO: 17Alison Leary, MSc, BA, BSc, RN, is Macmillan lecturer in oncology, University College London Hospital NHS Foundation TrustLung cancer remains the UK's biggest cancer killer, with over 33,000 people dying of lung cancer each year (Cancer Research UK, 2005). Despite improved survival rates in other cancers such as breast cancer, lung cancer survival rates in the UK have changed little in the last 30 years, with an average five-year survival of just 7%.

Subscribe for full online access and get...

  • Full, instant access to all stories
  • Customised email alerts straight to your inbox
  • 5,000+ practice articles in our clinical archive
  • Online learning units on fundamental aspects of nursing care

Register for guest access to keep reading and get...

  • A free taste of other selected news stories
  • Daily email newsletters

Speak with a member of the team about providing Nursing Times for your whole team
Are you a student nurse? Take advantage of a discounted rate by clicking here (Graduation date required)
Already have an account? Sign in